These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16566297)

  • 1. Exploiting directed evolution for the discovery of biologicals.
    Douthwaite J; Jermutus L
    Curr Opin Drug Discov Devel; 2006 Mar; 9(2):269-75. PubMed ID: 16566297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribosome-display technology: applications for directed evolution of functional proteins.
    Yan X; Xu Z
    Drug Discov Today; 2006 Oct; 11(19-20):911-6. PubMed ID: 16997141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ribosome display: next-generation display technologies for production of antibodies in vitro.
    He M; Khan F
    Expert Rev Proteomics; 2005 Jun; 2(3):421-30. PubMed ID: 16000087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolution of protein stability using ribosome display.
    Buchanan A
    Methods Mol Biol; 2012; 805():191-212. PubMed ID: 22094807
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug discovery beyond the 'rule-of-five'.
    Zhang MQ; Wilkinson B
    Curr Opin Biotechnol; 2007 Dec; 18(6):478-88. PubMed ID: 18035532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New genotype-phenotype linkages for directed evolution of functional proteins.
    Leemhuis H; Stein V; Griffiths AD; Hollfelder F
    Curr Opin Struct Biol; 2005 Aug; 15(4):472-8. PubMed ID: 16043338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro evolution of proteins for drug development.
    Delagrave S; Murphy DJ
    Assay Drug Dev Technol; 2003 Feb; 1(1 Pt 2):187-98. PubMed ID: 15090146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ribosome display: selecting and evolving proteins in vitro that specifically bind to a target.
    Zahnd C; Amstutz P; Plückthun A
    Nat Methods; 2007 Mar; 4(3):269-79. PubMed ID: 17327848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The design, structures and therapeutic potential of protein epitope mimetics.
    Robinson JA; Demarco S; Gombert F; Moehle K; Obrecht D
    Drug Discov Today; 2008 Nov; 13(21-22):944-51. PubMed ID: 18725320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creating the next generation of protein therapeutics through rational drug design.
    Szymkowski DE
    Curr Opin Drug Discov Devel; 2005 Sep; 8(5):590-600. PubMed ID: 16159021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fragment-based lead discovery: a chemical update.
    Erlanson DA
    Curr Opin Biotechnol; 2006 Dec; 17(6):643-52. PubMed ID: 17084612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Latest technologies for the enhancement of antibody affinity.
    Wark KL; Hudson PJ
    Adv Drug Deliv Rev; 2006 Aug; 58(5-6):657-70. PubMed ID: 16828920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel proteins in emulsions using in vitro compartmentalization.
    Rothe A; Surjadi RN; Power BE
    Trends Biotechnol; 2006 Dec; 24(12):587-92. PubMed ID: 17055094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in the search for drugs to treat central nervous system disorders.
    Enna SJ; Williams M
    J Pharmacol Exp Ther; 2009 May; 329(2):404-11. PubMed ID: 19182069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steering directed protein evolution: strategies to manage combinatorial complexity of mutant libraries.
    Wong TS; Roccatano D; Schwaneberg U
    Environ Microbiol; 2007 Nov; 9(11):2645-59. PubMed ID: 17922750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly efficient ribosome display selection by use of purified components for in vitro translation.
    Villemagne D; Jackson R; Douthwaite JA
    J Immunol Methods; 2006 Jun; 313(1-2):140-8. PubMed ID: 16730021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of CAT-354, a therapeutic antibody directed against interleukin-13, using ribosome display.
    Thom G; Minter R
    Methods Mol Biol; 2012; 805():393-401. PubMed ID: 22094818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.